Affinity proteomics within rare diseases: a BIO ‐ NMD study for blood biomarkers of muscular dystrophies-Reference-Cited by-同舟云学术

Affinity proteomics within rare diseases: a BIO ‐ NMD study for blood biomarkers of muscular dystrophies

Published:2014-06-11 Issue:7 Volume:6 Page:918-936
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Ayoglu Burcu¹,Chaouch Amina²,Lochmüller Hanns²,Politano Luisa³,Bertini Enrico⁴,Spitali Pietro⁵,Hiller Monika⁵,Niks Eric H⁶,Gualandi Francesca⁷,Pontén Fredrik⁸,Bushby Kate²,Aartsma‐Rus Annemieke²⁵,Schwartz Elena⁹,Le Priol Yannick¹⁰,Straub Volker²,Uhlén Mathias¹,Cirak Sebahattin¹¹,‘t Hoen Peter A C⁵,Muntoni Francesco¹²,Ferlini Alessandra⁷,Schwenk Jochen M¹,Nilsson Peter¹,Al‐Khalili Szigyarto Cristina¹³

Affiliation:

1. Affinity Proteomics SciLifeLab School of Biotechnology KTH‐Royal Institute of Technology Stockholm Sweden

2. Institute of Genetic Medicine Newcastle University Newcastle upon Tyne UK

3. Cardiomiology and Medical Genetics Department of Experimental Medicine Second University of Naples Naples Italy

4. Unit of Neuromuscular and Neurodegenerative Disorders Department of Neurosciences Bambino Gesú Children's Hospital Rome Italy

5. Department of Human Genetics Leiden University Medical Center Leiden The Netherlands

6. Department of Neurology Leiden University Medical Center Leiden The Netherlands

7. Unit of Medical Genetics Department of Medical Sciences University of Ferrara Ferrara Italy

8. SciLifeLab Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden

9. Ariadne Diagnostics Rockville MD USA

10. Elsevier Amsterdam The Netherlands

11. Research Center for Genetic Medicine Childrens National Medical Center Washington DC USA

12. The Dubowitz Neuromuscular Centre UCL Institute of Child Health London UK

13. Department of Proteomics School of Biotechnology KTH‐Royal Institute of Technology Stockholm Sweden

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201303724

Reference73 articles.

1. Serum protein profiling in mice: Identification of Factor XIIIa as a potential biomarker for muscular dystrophy

2. Effects of Leptin and Insulin on CA III Expression in Rat Adipose Tissue

3. The Human Plasma Proteome

4. Plasma 99th Percentile Reference Limits for Cardiac Troponin and Creatine Kinase MB Mass for Use with European Society of Cardiology/American College of Cardiology Consensus Recommendations

5. Antibodies for profiling the human proteome-The Human Protein Atlas as a resource for cancer research

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiology of malate dehydrogenase and how dysregulation leads to disease;Essays in Biochemistry;2024-07-04

2. Creatine Kinase-MM/Proto-oncogene Tyrosine-Protein Kinase Receptor as a Sensitive Indicator for Duchenne Muscular Dystrophy Carriers;Molecular Neurobiology;2024-05-20

3. Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease;Journal of Neuromuscular Diseases;2024-03-05

4. N-terminal titin fragment: a non-invasive, pharmacodynamic biomarker for microdystrophin efficacy;Skeletal Muscle;2024-01-16

5. How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?;Proteomes;2024-01-16